Goldman Sachs in talks to invest $350-M in PharmEasy

Goldman Sachs is in advanced talks to invest about $350 million (Rs 2,700 crore) in API Holdings, the parent of online pharmacy PharmEasy, in a structured debt transaction. The debt will carry an interest rate of 14-15% and also have a pre-agreed equity upside. The money will predominantly be used to refinance the debt the company had taken to fund its acquisition of diagnostics chain Thyrocare last year.